269 related articles for article (PubMed ID: 26524855)
21. Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.
Knol JC; de Wit M; Albrethsen J; Piersma SR; Pham TV; Mongera S; Carvalho B; Fijneman RJ; Meijer GA; Jiménez CR
Biochim Biophys Acta; 2014 May; 1844(5):1034-43. PubMed ID: 24361553
[TBL] [Abstract][Full Text] [Related]
22. Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
Uzozie AC; Selevsek N; Wahlander A; Nanni P; Grossmann J; Weber A; Buffoli F; Marra G
Mol Cell Proteomics; 2017 Mar; 16(3):407-427. PubMed ID: 28062797
[TBL] [Abstract][Full Text] [Related]
23. The discovery and validation of colorectal cancer biomarkers.
Ang CS; Phung J; Nice EC
Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer proteomics: The urgent need for clinically validated biomarkers.
Evans CA; Glen A; Eaton CL; Larré S; Catto JW; Hamdy FC; Wright PC; Rehman I
Proteomics Clin Appl; 2009 Feb; 3(2):197-212. PubMed ID: 26238619
[TBL] [Abstract][Full Text] [Related]
25. Identifying Clinically Relevant Proteins for Targeted Analysis in the Development of a Multiplexed Proteomic Biomarker Assay.
Mackay EM; Bathe OF
Methods Mol Biol; 2018; 1788():123-129. PubMed ID: 29569121
[TBL] [Abstract][Full Text] [Related]
26. A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery.
Sjöström M; Ossola R; Breslin T; Rinner O; Malmström L; Schmidt A; Aebersold R; Malmström J; Niméus E
J Proteome Res; 2015 Jul; 14(7):2807-18. PubMed ID: 25944384
[TBL] [Abstract][Full Text] [Related]
27. Comparative proteomic analysis for the insoluble fractions of colorectal cancer patients.
Yang HY; Kwon J; Park HR; Kwon SO; Park YK; Kim HS; Chung YJ; Chang YJ; Choi HI; Chung KJ; Lee DS; Park BJ; Jeong SH; Lee TH
J Proteomics; 2012 Jun; 75(12):3639-53. PubMed ID: 22564821
[TBL] [Abstract][Full Text] [Related]
28. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
Koshiyama A; Ichibangase T; Imai K
Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
[TBL] [Abstract][Full Text] [Related]
30. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
31. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry.
Chen JS; Chen KT; Fan CW; Han CL; Chen YJ; Yu JS; Chang YS; Chien CW; Wu CP; Hung RP; Chan EC
FEBS J; 2010 Jul; 277(14):3028-38. PubMed ID: 20546304
[TBL] [Abstract][Full Text] [Related]
32. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.
Yang Q; Bavi P; Wang JY; Roehrl MH
J Proteomics; 2017 Sep; 168():53-65. PubMed ID: 28669815
[TBL] [Abstract][Full Text] [Related]
33. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
34. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
[TBL] [Abstract][Full Text] [Related]
35. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
36. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
[TBL] [Abstract][Full Text] [Related]
37. Discovery of biomarkers for gastric cancer: a proteomics approach.
Lin LL; Huang HC; Juan HF
J Proteomics; 2012 Jun; 75(11):3081-97. PubMed ID: 22498886
[TBL] [Abstract][Full Text] [Related]
38. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
39. Proteomics of endometrial cancer diagnosis, treatment, and prognosis.
Mittal P; Klingler-Hoffmann M; Arentz G; Zhang C; Kaur G; Oehler MK; Hoffmann P
Proteomics Clin Appl; 2016 Mar; 10(3):217-29. PubMed ID: 26541900
[TBL] [Abstract][Full Text] [Related]
40. [Proteomics and biomarkers for detection of cervical cancer].
Kacerovský M; Tosner J
Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
